Check your blood pressure regularly and tell your doctor if the results are high
Signs of bleeding like throwing up or coughing up blood; vomit that looks Duloxetine 4/9
constant headaches, long-lasting confusion or weakness, or frequent muscle cramps – these can be signs of low sodium levels in your blood yellowing of the whites of your eyes, or
Hematologic side effects including anemia, leukopenia, increased white blood cell count, lymphadenopathy, and thrombocytopenia have been reported
People with depression have a consistently low mood and other symptoms
Trouble passing urine
Some of the common side effects of duloxetine will gradually improve as your body gets used to it
Duloxetine first received approval from the FDA in August, 2004 as Cymbalta for the treatment of Major Depressive Disorder
Taking blood thinners with duloxetine may increase A pooled analysis of six different placebo-controlled research studies found that 44
Cymbalta is an antidepressant that can cause side effects such as nausea, constipation, and drowsiness
¥ Agomelatine may be hepatotoxic and is contraindicated with any degree of liver impairment
Cymbalta’s more common side effects include: fatigue (lack of energy) nausea
* To learn more about this side effect, see Constipation
The physical side effects of duloxetine usually peak after 2-3 days and can persist for more than a week
In diabetic peripheral neuropathic pain, a 50% or better improvement with duloxetine 60 mg per day was just over one and a half times more likely than with
Duloxetine is a medication that has been used to treat depression, anxiety, and chronic pain
Dizziness or The recommended dose of Cymbalta for treating depression is 20 or 30 mg twice daily or 60 mg once daily
2 out of 10 from a total of 2,392 reviews on Drugs
Pediatric Neurology: 410-955-4259
The most common version of Cymbalta is covered by 62% of insurance plans
Uncommon (0
Body weight data were obtained from all 10 phase II and III registration studies of duloxetine in the treatment of MDD, as defined by the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV), 20 performed by Eli Lilly and Company between February 1999 and July 2003